← FDA DRUG APPROVALS

FDA ANDA · ANDA215794

METRONIDAZOLE

Sponsor: GLENMARK PHARMS LTD

APPLICATION
ANDA215794
TYPE
ANDA
ORIGINAL APPROVAL
2022-01-27
LATEST ACTION
2023-02-06
ROUTE
VAGINAL
DOSAGE FORM
GEL
MARKETING STATUS
Prescription

Products

METRONIDAZOLEPrescription
METRONIDAZOLE 0.75% · GEL · VAGINAL

Approval history

2023-02-06Manufacturing (CMC) · Supplement 1 · unknownAP
2022-01-27UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →